Compare CDW & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDW | STE |
|---|---|---|
| Founded | 1984 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9B | 25.9B |
| IPO Year | 1993 | 1992 |
| Metric | CDW | STE |
|---|---|---|
| Price | $146.35 | $263.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | $188.13 | ★ $268.25 |
| AVG Volume (30 Days) | ★ 1.4M | 674.3K |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | ★ 1.72% | 0.96% |
| EPS Growth | N/A | ★ 59.39 |
| EPS | ★ 7.91 | 6.97 |
| Revenue | ★ $22,099,100,000.00 | $5,702,415,000.00 |
| Revenue This Year | $6.74 | $9.24 |
| Revenue Next Year | $2.89 | $6.30 |
| P/E Ratio | ★ $18.49 | $37.72 |
| Revenue Growth | 6.09 | ★ 7.08 |
| 52 Week Low | $135.63 | $200.98 |
| 52 Week High | $222.92 | $268.60 |
| Indicator | CDW | STE |
|---|---|---|
| Relative Strength Index (RSI) | 50.97 | 59.06 |
| Support Level | $141.93 | $256.68 |
| Resistance Level | $145.39 | $268.60 |
| Average True Range (ATR) | 3.70 | 4.64 |
| MACD | 0.96 | -0.69 |
| Stochastic Oscillator | 92.89 | 65.59 |
CDW Corp is a multi-brand provider of information technology ("IT") solutions to small, medium, and large business, government, education, and healthcare customers in the United States, the United Kingdom, and Canada. The company's broad array of offerings ranges from discrete hardware and software products to integrated IT solutions and services that include on-premise and cloud capabilities across hybrid infrastructure, digital experience, and security. The company has five operating segments namely, Corporate, Small Business, Public, CDW UK, and CDW Canada. The Corporate segment generates the majority of its revenue and serves USA private sector business customers.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.